Skip to content

Survey of Patients Taking IOP-Lowering Eye Drops

A Multi-Site Questionnaire-Based Study to Assess Attitudes Regarding Current IOP-Lowering Eye Drops and Products in Development for Sustained Release of Medication in Glaucomatous and Ocular Hypertensive Subjects

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02384772
Enrollment
160
Registered
2015-03-10
Start date
2015-01-31
Completion date
2015-05-31
Last updated
2015-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Ocular Hypertension

Brief summary

Survey to assess perspectives of patients prescribed IOP-lowering eye drops at a single office visit.

Interventions

OTHERSurvey

Sponsors

ForSight Vision5, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Prescribed IOP-lowering eye drops

Exclusion criteria

* Can complete survey instrument in English

Design outcomes

Primary

MeasureTime frame
Descriptive Statistics of Subject Perceptions of Different IOP-Lowering TreatmentsA Single Office Visit

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026